5-R21-EB030071-04 |
Cherenkov luminescence mediated excitation of discrete lanthanide optical probes |
Eszter Boros |
University of Wisconsin-Madison |
2-R01-EB031008-05 |
Clinically Translatable MRI Reporter Genes and Imaging Methods with Ultra-High Specificity and Sensitivity |
Christian Farrar |
Massachusetts General Hospital |
5-R01-EB021155-08 |
Copper-mediated Radiofluorination: from Proof-of-Concept to Clinical Impact |
Peter Scott |
University of Michigan at Ann Arbor |
1-DP2-EB037187-01 |
Deep-tissue targeted molecular imaging with a palette of NIR-II emissive DNA-stabilized nanoclusters |
Stacy Copp |
University of California-Irvine |
1-K01-EB037630-01 |
Developing a library of near-infrared fluorophores for multiplexed in vivo fluorescence lifetime imaging of disease biomarkers. |
Rahul Pal |
Massachusetts Eye And Ear Infirmary |
5-R01-EB029429-04 |
Developing a pretargeting strategy to detect Fe(II) for nuclear medicine applications |
Michael Evans |
University of California, San Francisco |
1-R21-EB036580-01 |
Developing Hyperpolarized Nitrogen-15 MRI Agents for Probing Glutamine Metabolism |
Qiu Wang |
Duke University |
5-R01-EB029756-04 |
Developing Multimodal Multiplexed ImmunoPET-Raman Probes to Guide Immunotherapies |
Rizia Bardhan |
Iowa State University |
5-R03-EB033633-02 |
Developing Therapeutic Gel Embolic Agents for Arteriovenous Malformation Embolization |
Jingjie Hu |
North Carolina State University Raleigh |
5-R21-EB032025-03 |
Development and Evaluation of Radiotracers for PET Imaging Angiotensin-Converting Enzyme 2 (ACE2) |
Xuyi Yue |
Nemours Children'S Hospital, Delaware |